Results 71 to 80 of about 48,402 (236)

Physiotherapists’ perceptions of problematic musculoskeletal soft tissue disorders [PDF]

open access: yes, 2008
Original article can be found at: http://www.ijtr.co.uk/ Copyright MA Healthcare Limited.Aims: Many common musculoskeletal disorders are resistant to existing management strategies,causing long-term pain and disability.
Byrne, G., Poltawski, L., Watson, T.
core   +1 more source

Adult‐onset Coats disease: A systematic review and meta‐analysis of imaging biomarkers and targeted therapies

open access: yesActa Ophthalmologica, EarlyView.
Abstract Coats disease diagnosed in adulthood is a rare idiopathic retinal telangiectatic vasculopathy that may differ in phenotype from childhood‐diagnosed cases. This systematic review synthesizes current evidence to characterize its clinical spectrum, imaging features, treatment outcomes and underlying mechanisms, with a focus on immunovascular ...
Catarina Francisco   +2 more
wiley   +1 more source

The effect of cryotherapy application before versus after subcutaneous anticoagulant injection on pain intensity and hematoma formation: A quasi-experimental design

open access: yesInternational Journal of Nursing Sciences, 2018
Objective: To investigate the effect of cryotherapy application before versus after subcutaneous anticoagulant injection (SCAI) on pain intensity and hematoma formation. Methods: A quasi-experimental design was utilized.
Dalia Salah El-Deen, Naglaa F.A. Youssef
doaj   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

A Long‐Standing Palmar Depressed Macule

open access: yes
JEADV Clinical Practice, EarlyView.
Jhon Edwin Rodríguez‐Vásquez   +4 more
wiley   +1 more source

Focal therapy using a novel cooled laser device for prostate cancer: early trial results

open access: yesBJU International, EarlyView.
Objectives To determine the short‐term oncological results and safety of the ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT‐PC) trial, the first phase II clinical trial of ProFocal® (Medlogical Innovations, Sydney, Australia), a novel, cooled laser focal therapy (cLFT) device for prostate cancer (PCa) treatment. Patients and Methods Men with
Jonathan Kam   +17 more
wiley   +1 more source

Comparison of the effectiveness of whole-body cryotherapy and local cryotherapy for the treatment of rheumatoid arthritis

open access: yesSztuka Leczenia
Rheumatoid arthritis (RA) is a progressive autoimmune disease affecting connective tissue, leading to joint damage and multi-organ changes.
Marta Barłowska, Gabriela Zabierowska
doaj   +1 more source

A Recurrent Indurated Plaque on the Thigh

open access: yes
JEADV Clinical Practice, EarlyView.
Tram T. Tran   +3 more
wiley   +1 more source

Targeted microwave ablation of localised prostate cancer (VIOLETTE trial): a prospective multicentre study

open access: yesBJU International, EarlyView.
Objective To assess the oncological outcomes of targeted microwave ablation (TMA) using organ‐based tracking (OBT) Fusion® via KOELIS Trinity® (KOELIS, Meylan, France) in men with intermediate‐risk prostate cancer (PCa): the VIOLETTE trial (ClinicalTrials.gov identifier: NCT04582656) Patients and Method In this prospective phase II, multicentre ...
Nicolas Barry Delongchamps   +11 more
wiley   +1 more source

Efficacy and Safety of Cryotherapy in "See and Treat" Program in Jakarta Primary Health Centre

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2016
Objective: To evaluate the efficacy and safety of cryotherapy in "See and Treat" program in Jakarta Primary Health Care. Method: Using descriptive cross-sectional design, data from medical records were taken with total sampling method. We took the VIA
Linda Lestari   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy